Distal esophageal spasm: An update

Current Gastroenterology Reports

Volumn 15, Issue 9, 2013, Pages

  Achem, Sami R ^a   Gerson, Lauren B ^b,c  

^a MAYO CLINIC   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Division of Gastroenterology and Hepatology   (United States)

Author keywords

Botulinum toxin; Calcium channel blockers; Chest pain; Diffuse esophageal spasm; Dysphagia; Esophageal manometry; Esophageal motility disorder; Heller myotomy

Indexed keywords

ANTACID AGENT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DILTIAZEM; GLYCERYL TRINITRATE; HYOSCYAMINE; IMIPRAMINE; ISOSORBIDE DINITRATE; LONG ACTING DRUG; NIFEDIPINE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SHORT ACTING DRUG; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; GASTROINTESTINAL AGENT;

ARTICLE; BALLOON DILATATION; BEDTIME DOSAGE; BLEPHAROSPASM; CARDIOESOPHAGOMYOTOMY; CERVICAL DYSTONIA; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; DISTAL ESOPHAGEAL SPASM; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSPHAGIA; ENDOSCOPIC SURGERY; ESOPHAGEAL PRESSURE TOPOGRAPHY; ESOPHAGUS ACHALASIA; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS MUSCLE; ESOPHAGUS MYOTOMY; ESOPHAGUS PERFORATION; ESOPHAGUS SPASM; ESOPHAGUS SURGERY; GASTROESOPHAGEAL REFLUX; HUMAN; LOW DRUG DOSE; MEDICAL PROCEDURES; NONHUMAN; PATHOGENESIS; PER ORAL ENDOSCOPIC MYOTOMY; PRACTICE GUIDELINE; PREVALENCE; RECURRENT DISEASE; SMOOTH MUSCLE CONTRACTION; SPASMODIC DYSPHONIA; SYMPTOM; THORAX PAIN; TOPOGRAPHY; ALGORITHM; DILATATION; LOWER ESOPHAGUS SPHINCTER; MANOMETRY; METHODOLOGY; REVIEW; ESOPHAGEAL ACHALASIA; ESOPHAGEAL SPASM, DIFFUSE; PROCEDURES;

ALGORITHMS; DILATATION; DISEASE PROGRESSION; ESOPHAGEAL ACHALASIA; ESOPHAGEAL SPASM, DIFFUSE; ESOPHAGEAL SPHINCTER, LOWER; GASTROINTESTINAL AGENTS; HUMANS; MANOMETRY;

EID: 84880438398     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-013-0325-5     Document Type: Article

References (68)

1. Richter JE, Castell DO. Diffuse esophageal spasm: a reappraisal. Ann Intern Med. 1984;100:242-5. (Pubitemid 14188781)
2. Osgood H. A peculiar form of esophagismus. Boston Med Surg J. 1889;120:401-3.
3. Creamer B, Donoghue E, Code CF. Pattern of esophageal motility in diffuse spasm. Gastroenterology. 1958;34:782-96.
4. Almansa C, Heckman MG, DeVault KR, et al. Esophageal spasm: demographic, clinical, radiographic, and manometric features in 108 patients. Dis Esophagus. 2012;25:214-21.
5. Tsuboi K, Mittal SK. Diffuse esophageal spasm: has the term lost its relevance? Analysis of 217 cases. Dis Esophagus 2010. doi: 10.1111/j.1442-2050. 2010.01146.x
6. Katz PO, Dalton CB, Richter JE, et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med. 1987;106:593-7. (Pubitemid 17095048)
7. Rosen JM, Lavenbarg T, Cocjin J, et al. Diffuse Esophageal Spasm (DES) in Children Referred for Manometry. J Pediatr Gastroenterol Nutr. 2013;56(4):436-8. doi: 10.1097/MPG.0b013e31827a7883.
8. Murray JA, Ledlow A, Launspach J, et al. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology. 1995;109:1241-8.
9. Konturek JW, Gillessen A, Domschke W. Diffuse esophageal spasm: a malfunction that involves nitric oxide? Scand J Gastroenterol. 1995;30:1041-5.
10. Krieger-Grubel C, Hiscock R, Nandurkar S, et al. Physiology of diffuse esophageal spasm (DES)-when normal swallows are not normal. Neurogastroenterol Motil. 2010;22:1056-e279.
11. Sifrim D, Jafari J. Deglutitive inhibition, latency between swallow and esophageal contractions and primary esophageal motor disorders. J Neurogastroenterol Motil. 2012;18:6-12.
12. Bortolotti MLG, Bragaglia RB, Mattioli S, Possati L. Electromyographic study in diffuse esophageal spasm and achalasia. In: Wienbeck M, editor. Motility of the digestive tract. New York: Raven Press; 1982.
13. Herbella FA, Raz DJ, Nipomnick I, et al. Primary versus secondary esophageal motility disorders: diagnosis and implications for treatment. J Laparoendosc Adv Surg Tech A. 2009;19:195-8.
14. Mittal RK, Bhargava V, Lal H, et al. Effect of esophageal contraction on esophageal wall blood perfusion. Am J Physiol Gastrointest Liver Physiol. 2011;301:G1093-8.
15. Tutuian R, Mainie I, Agrawal A, et al. Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance-manometry. Am J Gastroenterol. 2006;101:464-9. (Pubitemid 43340920)
16. Tsuboi K, Hoshino M, Srinivasan A, et al. Insights gained from symptom evaluation of esophageal motility disorders: a review of 4,215 patients. Digestion. 2012;85:236-42.
17. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut. 2001;49:145-51. (Pubitemid 32601892)
18. Richter JE, Wu WC, Johns DN, et al. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci. 1987;32:583-92. (Pubitemid 17084874)
19. Clouse RE, Staiano A, Alrakawi A, et al. Application of topographical methods to clinical esophageal manometry. Am J Gastroenterol. 2000;95:2720-30.
20. Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24 Suppl 1:57-65.
21. Pandolfino JE, Roman S, Carlson D, et al. Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology. 2011;141:469-75.
22. Roman S, Kahrilas PJ. Distal esophageal spasm. Dysphagia. 2012;27:115-23.
23. Pohl D, Ciolino J, Roberts J, et al. Functional aspects of distal oesophageal spasm: the role of onset velocity and contraction amplitude on bolus transit. Dig Liver Dis. 2012;44:569-75.
24. Park SY, Rew JS. A patient with progression of diffuse esophageal spasm to classic achalasia. J Neurogastroenterol Motil. 2012;18:100-1.
25. Fontes LH, Herbella FA, Rodriguez TN, et al. Progression of diffuse esophageal spasm to achalasia: incidence and predictive factors. Dis Esophagus. 2012. doi: 10.1111/j.1442-2050.2012.01377.x.
26. Khatami SS, Khandwala F, Shay SS, et al. Does diffuse esophageal spasm progress to achalasia? A prospective cohort study. Dig Dis Sci. 2005;50:1605-10. (Pubitemid 41203650)
27. Prabhakar A, Levine MS, Rubesin S, et al. Relationship between diffuse esophageal spasm and lower esophageal sphincter dysfunction on barium studies and manometry in 14 patients. AJR Am J Roentgenol. 2004;183:409-13. (Pubitemid 38970334)
28. Achem SR, Kolts BE. Current medical therapy for esophageal motility disorders. Am J Med. 1992;92:98S-105S.
29. Hershcovici T, Achem SR, Jha LK, et al. Systematic review: the treatment of noncardiac chest pain. Aliment Pharmacol Ther. 2012;35:5-14.
30. Achem SR. Treatment of non-cardiac chest pain. Dis Mon. 2008;54:642-70.
31. Achem SR. Noncardiac chest pain-treatment approaches. Gastroenterol Clin North Am. 2008;37:859-78. ix.
32. Nasrallah SM, Tommaso CL, Singleton RT, et al. Primary esophageal motor disorders: clinical response to nifedipine. South Med J. 1985;78:312-5. (Pubitemid 15102012)
33. Drenth JP, Bos LP, Engels LG. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Aliment Pharmacol Ther. 1990;4:411-6. (Pubitemid 20268691)
34. Nguyen TM, Eslick GD. Systematic review: the treatment of noncardiac chest pain with antidepressants. Aliment Pharmacol Ther. 2012;35:493-500.
35. Wang W, Sun YH, Wang YY, et al. Treatment of functional chest pain with antidepressants: a meta-analysis. Pain Physician. 2012;15:E131-42.
36. Clouse RE, Lustman PJ, Eckert TC, et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology. 1987;92:1027-36. (Pubitemid 17046322)
37. Handa M, Mine K, Yamamoto H, et al. Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach. J Clin Gastroenterol. 1999;28:228-32. (Pubitemid 29141102)
38. Cannon 3rd RO, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330:1411-7. (Pubitemid 24139233)
39. Hayashi H, Mine K, Hosoi M, et al. Comparison of the esophageal manometric characteristics of idiopathic and reflux-associated esophageal spasm: evaluation by 24-hour ambulatory esophageal motility and pH monitoring. Dig Dis Sci. 2003;48:2124-31. (Pubitemid 38037297)
40. Achem SR, Kolts BE, MacMath T, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci. 1997;42:2138-45. (Pubitemid 27502004)
41. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998;115:42-9. (Pubitemid 28307286)
42. Brooks VB. Motor nerve filament block produced by botulinum toxin. Science. 1953;117:334-9.
43. Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology. 1987;37:616-23. (Pubitemid 17057937)
44. Jankovic J, Schwartz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology. 1993;43:834-6. (Pubitemid 23121985)
45. Jankovic J, Schwartz KS. Use of botulinum toxin in the treatment of hand dystonia. J Hand Surg Am. 1993;18:883-7. (Pubitemid 23289708)
46. Miller RH, Woodson GE, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. Arch Otolaryngol Head Neck Surg. 1987;113:603-5. (Pubitemid 17084550)
47. Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995;332:774-8.
48. Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology. 1996;110:1410-5. (Pubitemid 26134072)
49. Miller LS, Parkman HP, Schiano TD, et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci. 1996;41:2025-31. (Pubitemid 26366804)
50. Miller LS, Pullela SV, Parkman HP, et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol. 2002;97:1640-6. (Pubitemid 34761383)
51. Storr M, Allescher HD, Rosch T, et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injection of botulinum toxin: a prospective study with long term follow-up. Gastrointest Endosc. 2001;54:18A. (Pubitemid 33668684)
52. Irving JD, Owen WJ, Linsell J, et al. Management of diffuse esophageal spasm with balloon dilatation. Gastrointest Radiol. 1992;17:189-92.
53. Ebert EC, Ouyang A, Wright SH, et al. Pneumatic dilatation in patients with symptomatic diffuse esophageal spasm and lower esophageal sphincter dysfunction. Dig Dis Sci. 1983;28:481-5. (Pubitemid 13102914)
54. Gild A. Surgical treatment of cardiospasm; cardio-oesophageal myotomy. Med J Aust. 1948;2:658-61.
55. Paris F, Benages A, Berenguer J, et al. Pre- and postoperative manometric studies in diffuse esophageal spasm. J Thorac Cardiovasc Surg. 1975;70:126-32.
56. Leonardi HK, Shea JA, Crozier RE, et al. Diffuse spasm of the esophagus. Clinical manometric, and surgical considerations. J Thorac Cardiovasc Surg. 1977;74:736-43. (Pubitemid 8233056)
57. McGiffin D, Lomas C, Gardner M, et al. Long oesophageal myotomy for diffuse spasm of the oesophagus. Aust N Z J Surg. 1982;52:193-7. (Pubitemid 12124678)
58. Henderson RD, Ryder D, Marryatt G. Extended esophageal myotomy and short total fundoplication hernia repair in diffuse esophageal spasm: five-year review in 34 patients. Ann Thorac Surg. 1987;43:25-31. (Pubitemid 17004841)
59. Ellis Jr FH. Esophagomyotomy for noncardiac chest pain resulting from diffuse esophageal spasm and related disorders. Am J Med. 1992;92:129S-31S.
60. Eypasch EP, DeMeester TR, Klingman RR, et al. Physiologic assessment and surgical management of diffuse esophageal spasm. J Thorac Cardiovasc Surg. 1992;104:859-68. discussion 868-9.
61. Leconte M, Douard R, Gaudric M, et al. Functional results after extended myotomy for diffuse oesophageal spasm. Br J Surg. 2007;94:1113-8. (Pubitemid 350082858)
62. Henderson RD, Ryder DE. Reflux control following myotomy in diffuse esophageal spasm. Ann Thorac Surg. 1982;34:230-6. (Pubitemid 12061864)
63. Almansa C, Hinder RA, Smith CD, et al. A comprehensive appraisal of the surgical treatment of diffuse esophageal spasm. J Gastrointest Surg. 2008;12:1133-45.
64. Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42:265-71.
65. Shiwaku H, Inoue H, Beppu R, et al. Successful treatment of diffuse esophageal spasm by peroral endoscopic myotomy. Gastrointest Endosc. 2013;77:149-50.
66. Louis H, Covas A, Coppens E, et al. Distal esophageal spasm treated by peroral endoscopic myotomy. Am J Gastroenterol. 2012;107:1926-7.
67. Thomas E, Witt P, Willis M, et al. Nifedipine therapy for diffuse esophageal spasm. South Med J. 1986;79:847-9.
68. Davies HA, Lewis MJ, Rhodes J, et al. Trial of nifedipine for prevention of oesophageal spasm. Digestion. 1987;36:81-3. (Pubitemid 17028578)